Molecule Details
| InChIKey | ULOLUGXMKLIZGE-UHFFFAOYSA-N |
|---|---|
| Compound Name | 1-(3-(5-chloro-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl)phenyl)-N,N-dimethylmethanamine |
| Canonical SMILES | CN(C)Cc1cccc(-c2cc3c(-c4cnn(C)c4)c(Cl)cnc3[nH]2)c1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 8 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.76 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (8)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q9NQS7 | INCENP | Homo sapiens | Human | PF03941 PF12178 | 9.3 | IC50 | ChEMBL |
| Q96GD4 | AURKB | Homo sapiens | Human | PF00069 | 8.2 | IC50 | ChEMBL;BindingDB |
| O14965 | AURKA | Homo sapiens | Human | PF00069 | 8.2 | IC50 | ChEMBL |
| O75716 | STK16 | Homo sapiens | Human | PF00069 | 8.2 | pIC50 | TTD_MultiTarget |
| Q9ULW0 | TPX2 | Homo sapiens | Human | PF09041 PF06886 PF12214 | 8.2 | IC50 | ChEMBL |
| P11166 | SLC2A1 | Homo sapiens | Human | PF00083 | 6.6 | IC50 | ChEMBL |
| O97467 | ht1 | Plasmodium falciparum | Pathogen | PF00083 | 6.7 | IC50 | ChEMBL |
| O61059 | LmGT2 | Leishmania mexicana | Pathogen | PF00083 | 6.6 | IC50 | ChEMBL |